#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz / Journals / Perspectives in Surgery / 2020 - 7

Nosocomial pneumonias

Czech version

Authors: M. Kolář 1;  L. Doubravská 2
Authors‘ workplace: Ústav mikrobiologie Lékařské fakulty Univerzity Palackého v Olomouci 1;  Klinika anesteziologie, resuscitace a intenzivní medicíny Fakultní nemocnice Olomouc 2
Published in: Rozhl. Chir., 2020, roč. 99, č. 7, s. 293-298.
Category: Review
doi: https://doi.org/10.33699/PIS.2020.99.7.293–298

Overview

The paper provides clear definitions of the basic concepts of nosocomial pneumonias. Specifically, definitions and classifications of HAP and VAP, general treatment principles and specific recommended procedures for antibiotic therapy are given as applicable in the Czech Republic.

Keywords:

antibiotics – therapy – HAP – VAP

Sources
  1. Douglas IS. Pulmonary infections in critical/intensive care – rapid diagnosis and optimizing antimicrobial usage. Curr Opin Pulmon Med. 2017;23(3):198−203. doi:10.1097/MCP.0000000000000366.
  2. Torres A, Ewig S, Lode H, et al. Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensiv Care Med. 2009;35(1):9−29. doi:10.1007/s00134-008-1336-9.
  3. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995;274(8):639−44. doi:10.1001/jama.1995.03530080055041.
  4. Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302(21):2323−2329. doi:10.1001/jama.2009.1754.
  5. Schulgen G, Kropec A, Kappstein I, et al. Estimation of extra hospital stay attributable to nosocomial infections. J Clin Epidemiol. 2000;53(4):409−417. doi:10.1016/S0895-4356(99)00182-1.
  6. Herkel T, Uvizl R, Doubravska L, et al. Epidemiology of hospital-acquired pneumonia: Results of a Central European multicenter, prospective, observational study compared with data from the European region. Biomed Papers 2016;160(3):448−455. doi:10.5507/bp.2016.014.
  7. Werarak P, Kiratisin P, Thamlikitkul V. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance. J Med Assoc Thai 2010;93(Suppl.1):126−138.
  8. Tejada Artigas A, Bello Dronda S, Chacón Vallés E, et al. Risk factors for nosocomial pneumonia in critically ill trauma patients. Crit Care Med. 2001;29(2):304–309. doi:10.1097/00003246-200102000-00015.
  9. Piskin N, Aydemir H, Oztoprak N, et al. Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: Risk factors and impact on outcomes. BMC Infect Dis. 2012;12:268. doi:10.1186/1471-2334-12-268.
  10. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997;111(3):676-85. doi:10.1378/chest.111.3.676.
  11. Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections. A risk factor for hospital mortality among critically ill patients. Chest 1999;115(2):462−474. doi:10.1378/chest.115.2.462.
  12. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med. 2003;31(5):1312−1317. doi:10.1097/01.CCM.0000063087.93157.06.
  13. Wyncoll D, Camporota L. Number needed to treat and cost-effectiveness in the prevention of ventilator-associated pneumonia. Crit Care 2012;16(3):430. doi:10.1186/cc11346.
  14. American Thoracic Society and the Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388−416. doi:10.1164/rccm.200405-644ST.
  15. Doubravská L, Uvízl R, Gabrhelík T, et al. Nozokomiální pneumonie ve světle aktuálních doporučení – je prostor pro zlepšení péče o pacienta? Klin Mikrobiol Inf Lék. 2018;24(1):4−9.
  16. Chastre J, Fagon JY. Ventilator-associated Pneumonia. Am J Respir Crit Care Med. 2002;165(7):867−903. doi:10.1164/ajrccm.165.7.2105078.
  17. Pudová V, Htoutou Sedláková M, Kolář M. and working group. Clonality of bacterial pathogens causing hospital-acquired pneumonia. Curr Microbiol. 2016;73(3):312−316. doi:10.1007/s00284-016-1058-0.
  18. Uvizl R, Adamus M, Cerny V, et al. Patient survival, predictive factors and disease course of severe sepsis in Czech intensive care units: a multicentre, retrospective, observational study. Biomed Papers 2016;160(2):287−297. doi:10.5507/bp.2015.052.
  19. Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Inf Dis. 2016;63(5):61−111. doi:10.1093/cid/ciw353.
  20. Torres A, Niederman MS, Chastre J, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia. Eur Respir J. 2017;50(3):1−26. doi:10.1183/13993003.00582-2017.
  21. Ewig S, Welte T, Chastre J, et al. Re­thinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Inf Dis. 2010;10(4):279−287. doi:10.1016/S1473-3099(10)70032-3.
  22. Yap V, Datta D, Metersky ML. Is the present definition of health care–associated pneumonia the best way to define risk of infection with antibiotic-resistant pathogens? Inf Dis Clin North Ame­rica 2013;27(1):1−18. doi: 10.1016/j.idc.2012.11.002.
  23. Safdar N, Dezfulian C, Collard HR, et al. Clinical and economic consequences of ventilator-associated pneumonia: A systematic review. Crit Care Med. 2005;33(10):2184−2193. doi:10.1097/01.ccm.0000181731.53912.d9.
  24. Timsit JF, Esaied W, Neuville M, et al. Update on ventilator-associated pneumonia. F1000Research 2017;6:2061. doi:10.12688/f1000research.12222.1.
  25. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Inf. 2012;18(3):268−281. doi:10.1111/j.1469-0691.2011.03570.x.
  26. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Resp Crit Care Med. 1998;157(2):531−539. doi:10.1164/ajrccm.157.2.9705064.
  27. Martin-Loeches I, Torres A, Rinaudo M, et al. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms. J Inf. 2015;70(3):213−222. doi:10.1016/j.jinf.2014.10.004.
  28. Martin-Loeches I, Deja M, Koulenti D, et al. Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive Care Med. 2013;39(4):672−681. doi:10.1007/s00134-012-2808-5.
  29. Neu HC. The crisis in antibiotic resistance. Science 1992;257(5073):1064−1073. doi:10.1126/science.257.5073.1064.
  30. Kolář M, Urbánek K, Látal T. Antibiotic selection pressure and development of bacterial resistance. Intern J Antimicrob Agents 2001;17(5):357−363. doi:10.1016/S0924-8579(01)00317-X.
  31. Papajk J, Uvízl R, Kolář M. Vliv předchozí antibiotické terapie na epidemiologii ventilátorových pneumonií. Klin Mikrobiol Inf Lék. 2019;25:7−11.
  32. Uvízl R, Herkel T, Kolář M, et al. Nozokomiální pneumonie – optimální nastavení iniciální empirické antimikrobiální terapie. Int Med Prax. 2017;19(4):225−229.
  33. Uvizl R, Hanulik V, Husickova V, et al. Hospital-acquired pneumonia in ICU patients. Biomed Papers 2011;155(4):373−378. doi:10.5507/bp.2011.067.
  34. Kolář M. Respirační infekce a jejich léčba. Maxdorf Jessenius, Praha, 2016.
  35. Htoutou Sedláková M, Pudová V, Kolář M, et al. Bakteriální původci nozokomiálních pneumonií – multicentrická studie v České republice. Klin Mikrobiol Inf Lék. 2015;21(1):10−14.
  36. Gabrhelík T, Hanulík V, Jakubec P, et al. Porovnání validity různých vzorků biologického materiálu z dýchacích cest a jejich přínosu v detekci původců nozokomiální pneumonie. Klin Mikrobiol Inf Lék. 2015;21(1):4−9.
  37. Dalhoff K, Ewig S. Adult patients with nosocomial pneumonia: epidemiology, diagnosis, and treatment. Deuts Arzteblatt Intern. 2013;110(38):634−640. doi:10.3238/arztebl.2013.0634.
  38. Verhamme KM, de Coster W, de Roo L, et al. Pathogens in early-onset and late-onset intensive care unit-acquired pneumonia. Inf Control Hosp Epidemiol. 2007;28(4):389−397. doi:10.1086/511702.
Labels
Surgery Orthopaedics Trauma surgery
Technický vývoj robotické chirurgie
Endovenous laser ablation of saphenous vein – mid-term results confirm permanent closure and possibility to treat more lesions in one procedure
Implanted vagus nerve stimulation in 126 patients: surgical technique and complications
Clear cell renal carcinoma metastases to the pancreas
Surgical complications of decompressive craniectomy in patients with head injury
Morgagni hernia – case reports
Primary perineal hernia: a case report
Article was published in

Perspectives in Surgery

Issue 7
2020 Issue 7
Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#